CTAA-101

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCTAA-101
Drug Alias NameCTAA-101 (Cytochroma)CTAA-101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperphosphatemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOpko Renal Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOpko Renal Llc
Active IndicationsN/A
Inactive IndicationsHyperphosphatemia

Other Information

ATC CodeN/A
Related LinksN/A